Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At presen...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S075333222201068X |
_version_ | 1811340786520817664 |
---|---|
author | Piotr Londzin Agata Brudnowska Katarzyna Kurkowska Katarzyna Wilk Karolina Olszewska Łukasz Ziembiński Aleksandra Janas Urszula Cegieła Joanna Folwarczna |
author_facet | Piotr Londzin Agata Brudnowska Katarzyna Kurkowska Katarzyna Wilk Karolina Olszewska Łukasz Ziembiński Aleksandra Janas Urszula Cegieła Joanna Folwarczna |
author_sort | Piotr Londzin |
collection | DOAJ |
description | Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At present, they are more and more widely used in patients without diabetes. Since there were concerns that SGLT2 inhibitors may increase fracture risk in diabetes, the aim of the study was to examine the effect of dapagliflozin and canagliflozin on the musculoskeletal system of nondiabetic, healthy rats. The experiments were carried out on mature female rats, divided into the control rats and rats treated with dapagliflozin (1.4 mg/kg p.o.) or canagliflozin (4.2 mg/kg p.o.) for 4 weeks. Serum bone turnover markers, skeletal muscle strength and mass, bone mass, density, histomorphometric parameters and mechanical properties were determined. Administration of the drugs did not affect the skeletal muscle mass and strength. There was no effect on serum bone turnover markers, and bone mass and composition. However, administration of both drugs resulted in disorders of cancellous bone microarchitecture and worsening of bone mechanical properties. In conclusion, both SGLT2 inhibitors unfavorably affected the skeletal system of healthy rats. |
first_indexed | 2024-04-13T18:47:08Z |
format | Article |
id | doaj.art-4520766e8ad64cfbb14ae698db638acb |
institution | Directory Open Access Journal |
issn | 0753-3322 |
language | English |
last_indexed | 2024-04-13T18:47:08Z |
publishDate | 2022-11-01 |
publisher | Elsevier |
record_format | Article |
series | Biomedicine & Pharmacotherapy |
spelling | doaj.art-4520766e8ad64cfbb14ae698db638acb2022-12-22T02:34:33ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-11-01155113679Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic ratsPiotr Londzin0Agata Brudnowska1Katarzyna Kurkowska2Katarzyna Wilk3Karolina Olszewska4Łukasz Ziembiński5Aleksandra Janas6Urszula Cegieła7Joanna Folwarczna8Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandDepartment of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandCorresponding author.; Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, PolandSodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At present, they are more and more widely used in patients without diabetes. Since there were concerns that SGLT2 inhibitors may increase fracture risk in diabetes, the aim of the study was to examine the effect of dapagliflozin and canagliflozin on the musculoskeletal system of nondiabetic, healthy rats. The experiments were carried out on mature female rats, divided into the control rats and rats treated with dapagliflozin (1.4 mg/kg p.o.) or canagliflozin (4.2 mg/kg p.o.) for 4 weeks. Serum bone turnover markers, skeletal muscle strength and mass, bone mass, density, histomorphometric parameters and mechanical properties were determined. Administration of the drugs did not affect the skeletal muscle mass and strength. There was no effect on serum bone turnover markers, and bone mass and composition. However, administration of both drugs resulted in disorders of cancellous bone microarchitecture and worsening of bone mechanical properties. In conclusion, both SGLT2 inhibitors unfavorably affected the skeletal system of healthy rats.http://www.sciencedirect.com/science/article/pii/S075333222201068XSGLT2 inhibitorsBoneRats |
spellingShingle | Piotr Londzin Agata Brudnowska Katarzyna Kurkowska Katarzyna Wilk Karolina Olszewska Łukasz Ziembiński Aleksandra Janas Urszula Cegieła Joanna Folwarczna Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats Biomedicine & Pharmacotherapy SGLT2 inhibitors Bone Rats |
title | Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats |
title_full | Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats |
title_fullStr | Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats |
title_full_unstemmed | Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats |
title_short | Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats |
title_sort | unfavorable effects of sodium glucose cotransporter 2 sglt2 inhibitors on the skeletal system of nondiabetic rats |
topic | SGLT2 inhibitors Bone Rats |
url | http://www.sciencedirect.com/science/article/pii/S075333222201068X |
work_keys_str_mv | AT piotrlondzin unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT agatabrudnowska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT katarzynakurkowska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT katarzynawilk unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT karolinaolszewska unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT łukaszziembinski unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT aleksandrajanas unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT urszulacegieła unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats AT joannafolwarczna unfavorableeffectsofsodiumglucosecotransporter2sglt2inhibitorsontheskeletalsystemofnondiabeticrats |